| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 8, 2024 | Feb 9, 2024 | Compass Therapeutics, Inc. | CEO | Sell | 42.5 | -49,198 | -1.55% | ✗ | $71.3K |
| Nov 17, 2023 | Nov 21, 2023 | Compass Therapeutics, Inc. | COO | Sell | 42.5 | -64,415 | -4.34% | ✗ | $96.6K |
| Nov 22, 2022 | Nov 25, 2022 | Compass Therapeutics, Inc. | COO | Sell | 42.5 | -24,500 | -2.26% | ✗ | $103.7K |
| Nov 18, 2022 | Nov 22, 2022 | Compass Therapeutics, Inc. | COO | Sell | 42.5 | -22,261 | -1.01% | ✗ | $97K |